Novartis Gets Complete Response Letter from FDA for Investigational Bronchodilator QAB149 (Therapeutics Dailly)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Merck & Co earnings climb as Januvia and Isentress impress (Pharma Times)
US pharma lobbying bill soars (Pharma Times)
Non-adherence blamed for some ‘difficult’ asthma (OnMedica)
FDA Refines Requirements For Computer-Aided Detection (Health News Daily)
Pfizer-Wyeth merger analyzed (News-Medical)
Sanofi-aventis sees new opportunities in Quebec (Montreal Gazette)
SUBSCRIBE